Phio Pharmaceuticals Corp. Balance Sheet
PHIO|7 years of annual SEC 10-K data (FY2012-FY2020)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Phio Pharmaceuticals Corp. had $16M in total assets and $6M in shareholders' equity as of FY2020. Total debt stood at $231,000 as of FY2020.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | - | $3.6M | $12.9M | $5.1M | $503.0K |
| Current Assets | $15.2M | $7.3M | $15.2M | $3.8M | $13.1M | $14.7M | $5.4M |
| PP&E (Net) | $157.0K | $210.0K | $172.0K | $248.0K | $114.0K | $177.0K | $198.0K |
| Total Assets | $15.7M | $8.0M | $15.3M | $4.1M | $13.4M | $14.9M | $5.6M |
| Current Liabilities | $2.2M | $1.9M | $1.7M | $2.3M | $2.5M | $2.1M | $1.7M |
| Total Debt | $231.0K | - | - | - | - | - | - |
| Shareholders' Equity | $5.7M | $13.6M | $1.8M | $10.9M | $8.9M | -$5.8M | -$89.0K |